Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy.

Frakes J, Mellon EA, Springett GM, Hodul P, Malafa MP, Fulp WJ, Zhao X, Hoffe SE, Shridhar R, Meredith KL.

J Gastrointest Oncol. 2017 Oct;8(5):758-765. doi: 10.21037/jgo.2017.08.05.

2.

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes.

Prabhakaran S, Fulp WJ, Gonzalez RJ, Sondak VK, Kudchadkar RR, Gibney GT, Weber JS, Zager JS.

Am Surg. 2016 Nov 1;82(11):1109-1116.

PMID:
28877811
3.

Tumour radiosensitivity is associated with immune activation in solid tumours.

Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF.

Eur J Cancer. 2017 Oct;84:304-314. doi: 10.1016/j.ejca.2017.08.001. Epub 2017 Aug 29.

PMID:
28863385
4.

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes.

Prabhakaran S, Fulp WJ, Gonzalez RJ, Sondak VK, Kudchadkar RR, Gibney GT, Weber JS, Zager JS.

Am Surg. 2016 Nov 1;82(11):1109-1116.

PMID:
28206940
5.

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.

Zurawski G, Shen X, Zurawski S, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Klucar P, Wang Z, Foulds KE, Kao SF, Yu X, Sato A, Yates NL, LaBranche C, Stanfield-Oakley S, Kibler K, Jacobs B, Salazar A, Self S, Fulp W, Gottardo R, Galmin L, Weiss D, Cristillo A, Pantaleo G, Levy Y.

J Virol. 2017 Apr 13;91(9). pii: e01596-16. doi: 10.1128/JVI.01596-16. Print 2017 May 1.

6.

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF.

Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18.

PMID:
27993569
7.

Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Sudenga SL, Torres BN, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

Int J Cancer. 2017 Jan 15;140(2):337-345. doi: 10.1002/ijc.30452. Epub 2016 Oct 20.

8.

An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study.

Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Ponce EL, Giuliano AR.

Papillomavirus Res. 2015 Dec;1:126-135. Epub 2015 Oct 8.

9.

Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.

Rollison DE, Komrokji R, Lee JH, Hampras S, Fulp W, Fisher K, Baz R, Nishihori T, Xu Q, Olesnyckyj M, Kenvin L, Knight R, Sullivan D, Alsina M, Dalton W, Shain KH.

Leuk Lymphoma. 2017 Mar;58(3):560-568. doi: 10.1080/10428194.2016.1207763. Epub 2016 Jul 18.

PMID:
27424609
10.

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma.

Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ.

Ann Surg Oncol. 2016 Oct;23(11):3572-3578. doi: 10.1245/s10434-016-5293-1. Epub 2016 Jun 1.

PMID:
27251134
11.

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.

Rollison DE, Shain KH, Lee JH, Hampras SS, Fulp W, Fisher K, Al Ali NH, Padron E, Lancet J, Xu Q, Olesnyckyj M, Kenvin L, Knight R, Dalton W, List A, Komrokji RS.

Cancer Med. 2016 Jul;5(7):1694-701. doi: 10.1002/cam4.721. Epub 2016 Apr 20.

12.

Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study.

Pierce Campbell CM, Viscidi RP, Torres BN, Lin HY, Fulp W, Abrahamsen M, Lazcano-Ponce E, Villa LL, Kreimer AR, Giuliano AR.

J Infect Dis. 2016 Jul 1;214(1):45-8. doi: 10.1093/infdis/jiw083. Epub 2016 Feb 29.

13.

Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.

Suleiman Y, Dalia S, Liu JJ, Bowers JW, Padron E, Lancet JE, Fulp W, Moscinski LC, Komrokji RS, Zuckerman KS, Zhang L.

Leuk Res. 2016 Mar;42:52-8. doi: 10.1016/j.leukres.2016.01.015. Epub 2016 Feb 2.

PMID:
26894965
14.

Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.

Rashid OM, Pimiento JM, Gamenthaler AW, Nguyen P, Ha TT, Hutchinson T, Springett G, Hoffe S, Shridhar R, Hodul PJ, Johnson BL, Illig K, Armstrong PA, Centeno BA, Fulp WJ, Chen DT, Malafa MP.

Ann Surg Oncol. 2016 Apr;23(4):1371-9. doi: 10.1245/s10434-015-5006-1. Epub 2015 Dec 10.

PMID:
26661409
15.

Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.

Haake SM, Brooks SA, Welsh E, Fulp WJ, Chen DT, Dhillon J, Haura E, Sexton W, Spiess PE, Pow-Sang J, Rathmell WK, Fishman M.

Urol Oncol. 2016 Mar;34(3):122.e1-7. doi: 10.1016/j.urolonc.2015.09.015. Epub 2015 Nov 3.

16.

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.

Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, Antonia SJ, Gray JE, Eschrich SA, Chen DT, Cress WD, Haura EB, Beg AA.

Oncogene. 2016 Jun 16;35(24):3209-16. doi: 10.1038/onc.2015.375. Epub 2015 Oct 19.

17.

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

Torres-Roca JF, Fulp WJ, Caudell JJ, Servant N, Bollet MA, van de Vijver M, Naghavi AO, Harris EE, Eschrich SA.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):631-8. doi: 10.1016/j.ijrobp.2015.06.021. Epub 2015 Jun 25.

18.

The radiosensitivity index predicts for overall survival in glioblastoma.

Ahmed KA, Chinnaiyan P, Fulp WJ, Eschrich S, Torres-Roca JF, Caudell JJ.

Oncotarget. 2015 Oct 27;6(33):34414-22. doi: 10.18632/oncotarget.5437.

19.

Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Permuth-Wey J, Chen DT, Fulp WJ, Yoder SJ, Zhang Y, Georgeades C, Husain K, Centeno BA, Magliocco AM, Coppola D, Malafa M.

Cancer Prev Res (Phila). 2015 Sep;8(9):826-34. doi: 10.1158/1940-6207.CAPR-15-0094.

20.

Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.

Mahipal A, Shibata D, Siegel E, Springett G, Almhanna K, Fulp W, Williams-Elson I, Kim R.

Invest New Drugs. 2015 Oct;33(5):1093-9. doi: 10.1007/s10637-015-0277-8. Epub 2015 Aug 16.

PMID:
26275531
21.

STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.

Permuth-Wey J, Fulp WJ, Reid BM, Chen Z, Georgeades C, Cheng JQ, Magliocco A, Chen DT, Lancaster JM.

Int J Cancer. 2016 Feb 1;138(3):612-9. doi: 10.1002/ijc.29799. Epub 2015 Aug 28.

22.

Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes.

Abbott AM, Dossett LA, Loftus L, Sun W, Fulp W, Sokol GH, Laronga C.

Am J Surg. 2015 Oct;210(4):624-8. doi: 10.1016/j.amjsurg.2015.05.012. Epub 2015 Jun 29.

PMID:
26238075
23.

Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

Strom T, Hoffe SE, Fulp W, Frakes J, Coppola D, Springett GM, Malafa MP, Harris CL, Eschrich SA, Torres-Roca JF, Shridhar R.

Radiother Oncol. 2015 Oct;117(1):159-64. doi: 10.1016/j.radonc.2015.07.018. Epub 2015 Jul 30.

PMID:
26235848
24.

Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients.

Snow R, Reyna C, Johns C, Lee MC, Sun W, Fulp WJ, Kiluk JV, Laronga C.

Am J Surg. 2015 Oct;210(4):685-93. doi: 10.1016/j.amjsurg.2015.05.004. Epub 2015 Jun 26.

PMID:
26210706
25.

A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.

Griffin PT, Ho VQ, Fulp W, Nishihori T, Shain KH, Alsina M, Baz RC.

Cancer. 2015 Oct 15;121(20):3622-30. doi: 10.1002/cncr.29533. Epub 2015 Jul 6.

26.

Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.

Suleiman Y, Mahipal A, Shibata D, Siegel EM, Jump H, Fulp WJ, Springett GM, Kim R.

Cancer Chemother Pharmacol. 2015 Sep;76(3):481-7. doi: 10.1007/s00280-015-2814-8. Epub 2015 Jul 1.

PMID:
26126727
27.

Menopausal status does not predict Oncotype DX recurrence score.

Carr DN, Vera N, Sun W, Lee MC, Hoover S, Fulp W, Acs G, Laronga C.

J Surg Res. 2015 Sep;198(1):27-33. doi: 10.1016/j.jss.2015.05.034. Epub 2015 Jun 12.

PMID:
26095420
28.

Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.

Sudenga SL, Ingles DJ, Pierce Campbell CM, Lin HY, Fulp WJ, Messina JL, Stoler MH, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR.

Eur Urol. 2016 Jan;69(1):166-73. doi: 10.1016/j.eururo.2015.05.032. Epub 2015 Jun 6.

29.

A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer.

Ambe C, Fulp W, Springett G, Hoffe S, Mahipal A.

J Gastrointest Cancer. 2015 Sep;46(3):284-90. doi: 10.1007/s12029-015-9734-z. Review.

PMID:
26018826
30.

Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.

Tanvetyanon T, Lee JH, Fulp WJ, Schreiber F, Brown RH, Levine RM, Cartwright TH, Abesada-Terk G, Kim GP, Alemany C, Faig D, Sharp PV, Markham MJ, Malafa M, Jacobsen PB.

J Oncol Pract. 2015 Jul;11(4):332-7. doi: 10.1200/JOP.2014.001750. Epub 2015 May 19.

PMID:
25991639
31.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42. doi: 10.1016/j.ijrobp.2015.01.036. Epub 2015 Mar 30.

32.

A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting.

Fishman MN, Tomshine J, Fulp WJ, Foreman PK.

PLoS One. 2015 Apr 1;10(4):e0120877. doi: 10.1371/journal.pone.0120877. eCollection 2015. Review.

33.

Outcomes of Therasphere Radioembolization for Colorectal Metastases.

Abbott AM, Kim R, Hoffe SE, Arslan B, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Meredith KL, Almhanna K, Strosberg J, Shibata D, Fulp WJ, Shridhar R.

Clin Colorectal Cancer. 2015 Sep;14(3):146-53. doi: 10.1016/j.clcc.2015.02.002. Epub 2015 Feb 16.

PMID:
25795047
34.

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

McGraw KL, Zhang LM, Rollison DE, Basiorka AA, Fulp W, Rawal B, Jerez A, Billingsley DL, Lin HY, Kurtin SE, Yoder S, Zhang Y, Guinta K, Mallo M, Solé F, Calasanz MJ, Cervera J, Such E, González T, Nevill TJ, Haferlach T, Smith AE, Kulasekararaj A, Mufti G, Karsan A, Maciejewski JP, Sokol L, Epling-Burnette PK, Wei S, List AF.

Blood Cancer J. 2015 Mar 13;5:e291. doi: 10.1038/bcj.2015.11.

35.

Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.

Pierce Campbell CM, Kreimer AR, Lin HY, Fulp W, O'Keefe MT, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR.

Cancer Prev Res (Phila). 2015 Mar;8(3):190-6. doi: 10.1158/1940-6207.CAPR-14-0296. Epub 2015 Jan 9.

36.

If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records.

Quinn GP, Block RG, Clayman ML, Kelvin J, Arvey SR, Lee JH, Reinecke J, Sehovic I, Jacobsen PB, Reed D, Gonzalez L, Vadaparampil ST, Laronga C, Lee MC, Pow-Sang J, Eggly S, Franklin A, Shah B, Fulp WJ, Hayes-Lattin B.

J Oncol Pract. 2015 Mar;11(2):137-44. doi: 10.1200/JOP.2014.000786. Epub 2014 Dec 30.

37.

Acceptance and adherence to chemoprevention among women at increased risk of breast cancer.

Roetzheim RG, Lee JH, Fulp W, Matos Gomez E, Clayton E, Tollin S, Khakpour N, Laronga C, Lee MC, Kiluk JV.

Breast. 2015 Feb;24(1):51-6. doi: 10.1016/j.breast.2014.11.006. Epub 2014 Dec 6.

38.

Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval.

Jacobsen PB, Lee JH, Fulp W, Siegel EM, Shibata D, Laronga C, Gray J, Tanvetyanon T, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G Jr, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Malafa M.

J Oncol Pract. 2015 Jan;11(1):e103-9. doi: 10.1200/JOP.2014.001525. Epub 2014 Oct 28.

39.

Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study.

Ingles DJ, Pierce Campbell CM, Messina JA, Stoler MH, Lin HY, Fulp WJ, Abrahamsen M, Sirak BA, O'Keefe MT, Papenfuss M, Gage C, Carvalho da Silva R, Gonzalez Sosa R, Rojas Juarez O, Villa LL, Lazcano Ponce E, Giuliano AR.

J Infect Dis. 2015 Apr 1;211(7):1060-7. doi: 10.1093/infdis/jiu587. Epub 2014 Oct 24.

40.

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.

Pimiento JM, Chen DT, Centeno BA, Davis-Yadley AH, Husain K, Fulp WJ, Wang C, Zhang A, Malafa MP.

Pancreas. 2015 Jan;44(1):122-7. doi: 10.1097/MPA.0000000000000218.

41.

Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.

Coppola D, Balducci L, Chen DT, Loboda A, Nebozhyn M, Staller A, Fulp WJ, Dalton W, Yeatman T, Brem S.

J Geriatr Oncol. 2014 Oct 1;5(4):389-99. doi: 10.1016/j.jgo.2014.08.003. Epub 2014 Sep 11.

PMID:
25220188
42.

Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer.

Prithviraj GK, Baksh K, Fulp W, Meredith K, Hoffe S, Shridhar R, Almhanna K.

Dis Esophagus. 2015 Nov-Dec;28(8):782-7. doi: 10.1111/dote.12279. Epub 2014 Aug 25.

PMID:
25155802
43.

Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas.

Hampras SS, Viscidi RP, Helzlsouer KJ, Lee JH, Fulp WJ, Giuliano AR, Platz EA, Rollison DE.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2591-6. doi: 10.1158/1055-9965.EPI-14-0370. Epub 2014 Aug 15.

44.

Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval.

Laronga C, Gray JE, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G Jr, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D, Malafa M, Jacobsen PB.

J Am Coll Surg. 2014 Oct;219(4):638-45.e1. doi: 10.1016/j.jamcollsurg.2014.03.063. Epub 2014 Jul 1.

45.

Carboplatin and paclitaxel treatment is effective in advanced anal cancer.

Kim R, Byer J, Fulp WJ, Mahipal A, Dinwoodie W, Shibata D.

Oncology. 2014;87(2):125-32. doi: 10.1159/000361051. Epub 2014 Jul 8.

PMID:
25012155
46.

Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.

Wong J, Fulp WJ, Strosberg JR, Kvols LK, Centeno BA, Hodul PJ.

Am J Surg. 2014 Nov;208(5):775-780. doi: 10.1016/j.amjsurg.2014.04.003. Epub 2014 Jun 8.

PMID:
24997491
47.

The impact of pathologic nodal status on survival following neoadjuvant chemoradiation for locally advanced rectal cancer.

Hernandez JM, Clark W, Weber J, Fulp WJ, Lange L, Shibata D.

Int J Colorectal Dis. 2014 Sep;29(9):1061-8. doi: 10.1007/s00384-014-1917-8. Epub 2014 Jun 27.

PMID:
24970021
48.

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.

Song L, Smith MA, Doshi P, Sasser K, Fulp W, Altiok S, Haura EB.

J Thorac Oncol. 2014 Jul;9(7):974-82. doi: 10.1097/JTO.0000000000000193.

49.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
50.

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.

Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE.

Am J Hematol. 2014 Aug;89(8):809-12. doi: 10.1002/ajh.23749. Epub 2014 May 16.

Supplemental Content

Support Center